Krishna Ella
- All
- News
- Videos
-
"Remarkable Influence": Bharat Biotech Co-Founder Honoured By Johns Hopkins
Dr Krishna Ella, co-founder and Executive Chairman of Bharat Biotech, has been awarded the prestigious Dean's medal by the Johns Hopkins Bloomberg School of Public Health, the Hyderabad-based pharma company said on Friday.
-
3 Lakh Doses Of Intranasal Covid Vaccine Sent To Hospital: Bharat Biotech
Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday.
-
Bharat Biotech Expects Regulator's Nod For Intranasal Covid Vaccine In Aug
Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, Chairman and Managing Director of BBIL, Krishna Ella said.
-
Covid Nasal Vaccine's Phase 3 Trials Completed, Says Bharat Biotech Chief
Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India next month.
-
Chief Justice Stresses On Respecting Mother, Mother Tongue And Motherland
Chief Justice of India NV Ramana on Thursday presented the Dr Ramineni Foundation's awards to vaccine maker Bharat Biotech's MD Krishna Ella and several others for their meritorious services.
-
Booster Dose Required If Covid Virus Gets Mutated: Bharat Biotech Chief
People will need booster doses of the COVID-19 vaccine would be required if the COVID-19 virus gets mutated, said Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella.
-
"Significant Success": Bharat Biotech Lauds Government Over 100 Crore Jabs
As India on Thursday achieved the milestone of administering 100 crore COVID-19 vaccine doses so far, Chairman and Managing Director of Bharat Biotech Dr Krishna Ella lauded the government's system for this achievement.
-
"Proud To Have Contributed": Bharat Biotech On 1 Billion Covid Jab Feat
As India on Thursday crossed 100 crore COVID-19 vaccination, Bharat Biotech's Chairman and Managing Director Dr Krishna Ella said that the firm is proud to have contributed to this 'historic landmark'.
-
Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman and Managing Director of Bharat Biotech, Krishna Ella said.
-
Coronavirus Vaccination: Centre To Compare Covaxin, Covishield Vaccines On Different Parameters
The Ministry of Health and Family Welfare (MoHFW) said on Thursday that the government will compare the coronavirus vaccines - Covishield and Covaxin on different parameters for the purposes of recordkeeping.
-
4 New Units To Manufacture 700 Million Vaccine Doses A Year: Bharat Biotech
Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, today said they are setting up four vaccine manufacturing facilities with a combined capacity of 700 million doses per year.
-
Covaxin Can Work Against Mutated Coronavirus, Says Bharat Biotech
Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of coronavirus, Chairman and Managing Director of the city-based vaccine maker Krishna Ella said on Tuesday.
-
A New, 'Made in India' Rotavirus Vaccine Might be the World's Cheapest
A new, super-cheap, 'Made in India' Rotavirus vaccine launched on Monday has the potential to drastically reduce the country's high infant mortality rate due to diarrohea.
-
PM Narendra Modi Launches Rotavirus Vaccine Developed in India
Prime Minister Narendra Modi on Monday launched Rotavirus vaccine Rotavac, developed by Hyderabad-based Bharat Biotech.
-
"Remarkable Influence": Bharat Biotech Co-Founder Honoured By Johns Hopkins
Dr Krishna Ella, co-founder and Executive Chairman of Bharat Biotech, has been awarded the prestigious Dean's medal by the Johns Hopkins Bloomberg School of Public Health, the Hyderabad-based pharma company said on Friday.
-
3 Lakh Doses Of Intranasal Covid Vaccine Sent To Hospital: Bharat Biotech
Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday.
-
Bharat Biotech Expects Regulator's Nod For Intranasal Covid Vaccine In Aug
Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, Chairman and Managing Director of BBIL, Krishna Ella said.
-
Covid Nasal Vaccine's Phase 3 Trials Completed, Says Bharat Biotech Chief
Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India next month.
-
Chief Justice Stresses On Respecting Mother, Mother Tongue And Motherland
Chief Justice of India NV Ramana on Thursday presented the Dr Ramineni Foundation's awards to vaccine maker Bharat Biotech's MD Krishna Ella and several others for their meritorious services.
-
Booster Dose Required If Covid Virus Gets Mutated: Bharat Biotech Chief
People will need booster doses of the COVID-19 vaccine would be required if the COVID-19 virus gets mutated, said Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella.
-
"Significant Success": Bharat Biotech Lauds Government Over 100 Crore Jabs
As India on Thursday achieved the milestone of administering 100 crore COVID-19 vaccine doses so far, Chairman and Managing Director of Bharat Biotech Dr Krishna Ella lauded the government's system for this achievement.
-
"Proud To Have Contributed": Bharat Biotech On 1 Billion Covid Jab Feat
As India on Thursday crossed 100 crore COVID-19 vaccination, Bharat Biotech's Chairman and Managing Director Dr Krishna Ella said that the firm is proud to have contributed to this 'historic landmark'.
-
Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman and Managing Director of Bharat Biotech, Krishna Ella said.
-
Coronavirus Vaccination: Centre To Compare Covaxin, Covishield Vaccines On Different Parameters
The Ministry of Health and Family Welfare (MoHFW) said on Thursday that the government will compare the coronavirus vaccines - Covishield and Covaxin on different parameters for the purposes of recordkeeping.
-
4 New Units To Manufacture 700 Million Vaccine Doses A Year: Bharat Biotech
Bharat Biotech, which has been accorded Emergency Use Authorisation from the drug regulator for its COVID-19 vaccine Covaxin, today said they are setting up four vaccine manufacturing facilities with a combined capacity of 700 million doses per year.
-
Covaxin Can Work Against Mutated Coronavirus, Says Bharat Biotech
Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of coronavirus, Chairman and Managing Director of the city-based vaccine maker Krishna Ella said on Tuesday.
-
A New, 'Made in India' Rotavirus Vaccine Might be the World's Cheapest
A new, super-cheap, 'Made in India' Rotavirus vaccine launched on Monday has the potential to drastically reduce the country's high infant mortality rate due to diarrohea.
-
PM Narendra Modi Launches Rotavirus Vaccine Developed in India
Prime Minister Narendra Modi on Monday launched Rotavirus vaccine Rotavac, developed by Hyderabad-based Bharat Biotech.
